ITCC-054 BOSUTINIB/BCHILD
A phase I/II study of Bosutinib in pediatric patients with Chronic Myeloid Leukemia who are resistant or intolerant to at least one prior Tyrosine Kinase Inhibitor therapy
Promotor Name : Erasmus
Investigator Name : Zwaan Michel
Trial registered on clinicaltrial.gov: NCT04258943